The Centers for Medicare & Medicaid Services has delayed 2020 private payer data reporting for the Clinical Diagnostic Test Payment System until 2021 for tests that are not advanced diagnostic laboratory tests, as required by recent legislation extending funding for federal programs through fiscal year 2020. Under the legislation, applicable laboratories, including hospital outreach laboratories, that were to report data between Jan. 1 and March 31, 2020, will instead report the data between Jan. 1, 2021, and March 31, 2021. Data reporting then will resume on a three-year cycle beginning in 2024. In addition, CMS may not reduce 2020 payment rates for clinical diagnostic laboratory tests that are not advanced or new tests by more than 10% in 2020 and by more than 15% per year in 2021, 2022 or 2023. Congress also directed the Medicare Payment Advisory Commission to study and report within 18 months on the least burdensome data collection process that would lead to a “representative and statistically valid data sample of private market rates from all laboratory segments,” including hospital outreach laboratories. The study will consider the variability of private market rates and the appropriate statistical methods for estimating representative rates. 
 

Related News Articles

Headline
The Department of Health and Human Services yesterday announced it has expanded the providers eligible for its Public Health and Social Services Emergency Fund…
Headline
The Centers for Medicare & Medicaid Services does not intend for Paycheck Protection Program funds to impact Medicare payments to rural hospitals, CMS…
Headline
Sens. Mark Warner, D-Va., and Tim Scott, R-S.C., today introduced the Getting Early Treatment and Comprehensive Assessments Reduces Emergencies (GET CARE) Act…
Headline
The Centers for Medicare & Medicaid Services Aug. 4 released a proposed rule that would retroactively incorporate Medicare Advantage days into the Medicare…
Headline
The Centers for Medicare & Medicaid Services yesterday announced that for 2021 the average basic premium for Medicare Part D prescription drug plans will…
Headline
Nearly 44% of primary care visits for Medicare fee-for-service beneficiaries were telehealth visits in April, up from 0.1% in February, according to a report…